Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Dow
Federal Trade Commission
Medtronic
Healthtrust
Daiichi Sankyo
Mallinckrodt
Express Scripts
Deloitte

Generated: April 23, 2018

DrugPatentWatch Database Preview

AMINOSYN 3.5% Drug Profile

« Back to Dashboard

Which patents cover Aminosyn 3.5%, and when can generic versions of Aminosyn 3.5% launch?

Aminosyn 3.5% is a drug marketed by Icu Medical Inc and Abbott and is included in five NDAs.

The generic ingredient in AMINOSYN 3.5% is amino acids; dextrose. There are three hundred and forty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; dextrose profile page.

US Patents and Regulatory Information for AMINOSYN 3.5%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc AMINOSYN 3.5% amino acids INJECTABLE;INJECTION 017789-004 Approved Prior to Jan 1, 1982 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbott AMINOSYN 3.5% M IN PLASTIC CONTAINER amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride INJECTABLE;INJECTION 018875-002 Aug 8, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Icu Medical Inc AMINOSYN 3.5% M amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride INJECTABLE;INJECTION 017789-003 Approved Prior to Jan 1, 1982 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbott AMINOSYN 3.5% W/ DEXTROSE 25% IN PLASTIC CONTAINER amino acids; dextrose INJECTABLE;INJECTION 019118-001 Oct 11, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cerilliant
Daiichi Sankyo
QuintilesIMS
Citi
AstraZeneca
Express Scripts
McKesson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.